- Cyclooxygenase-2: A Potential Target in Human Cancer
-
Won JH
- KMID: 2166143
- Cancer Res Treat.
- 2004 Jun;36(3):161-162.
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Expression of Cyclooxygenase (COX)-2 as a Prognostic Factor in Nasopharyngeal Cancer
-
Kim K, Wu HG, Park SW, Kim CJ, Park CI
- KMID: 2166149
- Cancer Res Treat.
- 2004 Jun;36(3):187-191.
PURPOSE: To evaluate the relationship between treatment failure and COX-2 expression in nasopharyngeal cancer patients treated with chemotherapy and radiotherapy. MATERIALS AND METHODS: The subjects of this study were 22 nasopharyngeal... -
- CITED
-
- Close
- SHARE
-
- Close
- Lung Cancer Screening with Low-Dose Chest CT: Current Issues
-
Ahn MI
- KMID: 2166144
- Cancer Res Treat.
- 2004 Jun;36(3):163-166.
Computed tomography offers many advantages over routine radiographs in screening for lung cancer, and it is clear that low-dose spiral CT screening can more frequently find considerably smaller lung cancers... -
- CITED
-
- Close
- SHARE
-
- Close
- The Efficacy of a Modified Chronomodulated Infusion of Oxaliplatin, 5-Fluorouracil and Leucovorin in Advanced Colorectal Cancer (Preliminary Data)
-
Park JY, Kim SY, Lee JJ, Yoon HJ, Cho KS
- KMID: 2166151
- Cancer Res Treat.
- 2004 Jun;36(3):199-204.
PURPOSE: To determine the efficacy and tolerability of a modified chronomodulated infusion of oxaliplatin, 5-fluorouracil (5-FU) and leucovorin in the treatment of advanced colorectal cancer. MATERIALS AND METHODS: Sixteen patients with... -
- CITED
-
- Close
- SHARE
-
- Close
- Predictive Value of Preoperative Serum CEA, CA19-9 and CA125 Levels for Peritoneal Metastasis in Patients with Gastric Carcinoma
-
Hwang GI, Yoo CH, Sohn BH, Shin JH, Park YL, Kim HD, Kim YS, Han WK, Pae WK
- KMID: 2166147
- Cancer Res Treat.
- 2004 Jun;36(3):178-181.
PURPOSE: Peritoneal metastasis is a crucial factor for the prognosis in gastric cancer, but its diagnosis is difficult before laparotomy. This study analyzed the usefulness of diagnostic imaging and various... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Value of Cyclooxygenase-2 Expression in Human Breast Carcinoma
-
Ahn JH, Kim SB, Ahn SH, Gong GY, Ahn MJ, Kang YK, Lee JS, Kim WK
- KMID: 2166150
- Cancer Res Treat.
- 2004 Jun;36(3):192-198.
PURPOSE: To determine whether COX-2 expression is associated with clinicopathological parameters, including c-erb-B2 overexpression and angiogenesis, and the disease- free survival of patients with operable breast cancer. MATERIALS AND METHODS: Paraffin-embedded... -
- CITED
-
- Close
- SHARE
-
- Close
- Combination of Gemcitabine and Cisplatin as First-Line Therapy in Advanced Non-Small-Cell Lung Cancer
-
Lee NS, Byun JH, Bae SB, Kim CK, Lee KT, Park SK, Won JH, Hong DS, Park HS
- KMID: 2166146
- Cancer Res Treat.
- 2004 Jun;36(3):173-177.
PURPOSE: The prognosis of patients with advanced non-small-cell lung cancer (NSCLC) is extremely poor. Many prospective randomized trials on patients with advanced NSCLC suggested systemic chemotherapy improves both the survival... -
- CITED
-
- Close
- SHARE
-
- Close
- Combination Chemotherapy of Heptaplatin, Paclitaxel and 5-Fluorouracil in Patients with Advanced Gastric Cancer: a Pilot Study
-
Ahn MJ, Oh HS, Choi JH, Lee YY, Kim IS, Choi IY, Lee OY, Choi HS, Kwon SJ
- KMID: 2166148
- Cancer Res Treat.
- 2004 Jun;36(3):182-186.
PURPOSE: To evaluate the efficacy and toxicity of heptaplatin, paclitaxel, and 5-fluorouracil combination chemotherapy in patients with advanced gastric cancer. MATERIALS AND METHODS: Between July 2002 and September 2003, nineteen patients... -
- CITED
-
- Close
- SHARE
-
- Close
- Expression of c-kit and p53 in Non-small Cell Lung Cancers
-
Yoo J, Kim CH, Song SH, Shim BY, Jeong YJ, Ahn MI, Kim SW, Cho DG, Jo MS, Cho KD, Cho HJ, Kim HK
- KMID: 2166145
- Cancer Res Treat.
- 2004 Jun;36(3):167-172.
PURPOSE: Increasing experimental evidence indicates that abnormal expression of c-kit may be implicated in the pathogenesis of a variety of solid tumors. It has been reported that over 70% of... -
- CITED
-
- Close
- SHARE
-
- Close
